Featured Research

from universities, journals, and other organizations

Cardiology: Stressed-out Hearts Put MEF2D To Work

Date:
December 18, 2007
Source:
Journal of Clinical Investigation
Summary:
Injury to the human heart, such as caused by high blood pressure and heart attack, results in the enlargement of heart muscle cells (cardiomyocyte hypertrophy) and the activation of a fetal program of cardiac gene expression. This pathological response leads to heart failure and death. On a molecular level, this pathological response is driven by enhanced expression of genes in response to the presence of proteins named transcription factors, including the MEF2 family of transcription factors.

Injury to the human heart, such as caused by high blood pressure and heart attack, results in the enlargement of heart muscle cells (cardiomyocyte hypertrophy) and the activation of a fetal program of cardiac gene expression.

This pathological response leads to heart failure and death. On a molecular level, this pathological response is driven by enhanced expression of genes in response to the presence of proteins named transcription factors, including the MEF2 family of transcription factors.

However, whether the MEF2 transcription factors are required for heart disease to occur had not been determined. A new study by Eric Olsen and his colleagues at the University of Texas Southwestern Medical Center, Dallas, has now revealed a unique role for MEF2D in regulating the pathological cardiac response to stress in adult mouse hearts.

The researchers generated mice deficient in MEF2D, and found that hearts from these mice exhibited blunted responses to cardiac stress.

In particular, pressure overload in the hearts of these mice resulted in reduced cardiomyocyte hypertrophy, fetal gene activation, and scarring compared with normal mice. Similar results were seen when cardiac stress was induced with injection of a drug known to cause these conditions.

In contrast, overproduction of MEF2D in mice resulted in profound heart disease, evidenced by extensive scarring of the heart tissue, heart dilation, pathological blood clotting, and severely congested lungs and liver. Because MEF2 transcription factors are found in almost all the tissues in the body, the authors concluded from these data that in addition to affecting stress-induced remodeling of the heart, altering MEF2 protein expression might also be a useful therapy for various noncardiac diseases.

Journal article: The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. Journal of Clinical Investigation. Dec 13, 2007.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Cardiology: Stressed-out Hearts Put MEF2D To Work." ScienceDaily. ScienceDaily, 18 December 2007. <www.sciencedaily.com/releases/2007/12/071213194119.htm>.
Journal of Clinical Investigation. (2007, December 18). Cardiology: Stressed-out Hearts Put MEF2D To Work. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2007/12/071213194119.htm
Journal of Clinical Investigation. "Cardiology: Stressed-out Hearts Put MEF2D To Work." ScienceDaily. www.sciencedaily.com/releases/2007/12/071213194119.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins